Loading
Imagion Biosystems Limited Stock: price and insider trades · Australia
1 insider bought €15k of shares over the last 90 days, the latest filed 25 Aug 2026.
Imagion Biosystems Limited: what insiders have been doing
Insider filings for Imagion Biosystems Limited are scarce in the ASX feed, the latest one published on 25 August 2026. This page will fill in as new trades are disclosed. These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.
Insider Decl.
1
Thresholds
n/a
Buy Volume
€15,330
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleRobert Romeo Proulx1 buy
Since the insiders bought
- -30.0%Entry A$0.01 · Close at T+30 A$0.01
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
A$0.01
Analyst consensus
Income statement
RevenueA$1.2M
Gross profitA$1.2M100% margin
EBITDA-A$3.5M-298% margin
Net income-A$4.3M-371.4% margin
Valuation
Beta-0.23
Balance sheet & cash
Market capA$5.6M
Total debtA$2.6M
Free Cash Flow-A$4M
Profitability & ownership
ROA-319.7%
% insiders14.8%
% institutions0.0%
Last declaration on 25 August 2026
Declarations1 total
@ A$0.0120.44% mcap100.0% of flowShareASXISIN AU000000IBX6ASX:2924-03125734-3A699751
Canonical exit: 23 Nov 2026 (T+90)
1 of 1 declaration
About Imagion Biosystems Limited
Imagion Biosystems Limited is a company listed on the XASX, specializing in the development of medical imaging technologies. It focuses on innovative solutions for the early diagnosis of cancer.
